EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer’s disease

Thomas Gérard iD, Lise Colmant iD, Vincent Malotaux iD, Yasmine Salman iD, Lara Huyghe iD, Lisa Quenon iD, Laurence Dricot iD, Adrian Ivanoiu, Renaud Lhommel iD, Bernard Hanseeuw iD

European Journal of Nuclear Medicine and Molecular Imaging · 2024-05 · 51 (6) · 1662-1674

DOI: 10.1007/s00259-024-06603-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 17.01.2024. Verfasst von Thomas Gérard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, Cliniques Universitaires Saint Luc, Brussels, Belgium. Thomas.gerard@uclouvain.be. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Alzheimer Disease, Cognition, Isoquinolines. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds De La Recherche Scientifique - FNRS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose [ 18 F]MK-6240, a second-generation tau PET tracer, is increasingly used for the detection and the quantification of in vivo cerebral tauopathy in Alzheimer’s disease (AD). Given that neurological symptoms are better explained by the topography rather than by the nature of brain lesions, our study aimed to evaluate whether cognitive impairment would be more closely associated with the spatial extent than with the intensity of tau-PET signal, as measured by the standard uptake value ratio (SUVr). Methods [ 18 F]MK6240 tau-PET data from 82 participants in the AD spectrum were quantified in three different brain regions ( Braak ≤ 2 , Braak ≤ 4 , and Braak ≤ 6 ) using SUVr and the extent of tauopathy (EOT, percentage of voxels with SUVr ≥ 1.3). PET data were first compared between diagnostic categories, and ROC curves were computed to evaluate sensitivity and specificity. PET data were then correlated to cognitive performances and cerebrospinal fluid (CSF) tau values.

Results

The EOT in the Braak ≤ 2 region provided the highest diagnostic accuracies, distinguishing between amyloid-negative and positive clinically unimpaired individuals (threshold = 9%, sensitivity = 79%, specificity = 82%) as well as between prodromal AD and preclinical AD (threshold = 38%, sensitivity = 81%, specificity = 93%). The EOT better correlated with cognition than SUVr (∆R 2 + 0.08–0.09) with the best correlation observed for EOT in the Braak ≤ 4 region ( R 2 = 0.64). Cognitive performances were more closely associated with PET metrics than with CSF values.

Conclusions

Quantifying [ 18 F]MK-6240 tau PET in terms of EOT rather than SUVr significantly increases the correlation with cognitive performances. Quantification in the mesiotemporal lobe is the most useful to diagnose preclinical AD or prodromal AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyAlzheimer DiseaseCognitionIsoquinolinesHumansMaleFemaleAgedtau ProteinsAged, 80 and overMiddle AgedTauopathiesBrainBiological TransportRadiopharmaceuticals

Stichwörter der Autor:innen

Biomarker of Alzheimer’s diseaseBrain imagingF18-MK6240SUVrTau PETTauopathy

Substanzen

MK-6240tau ProteinsRadiopharmaceuticalsIsoquinolines

Autor:innen und Institutionen

  • Nuclear Medicine Department, Cliniques Universitaires Saint Luc, Brussels, Belgium. Thomas.gerard@uclouvain.be.
  • Institute of Neurosciences, Université Catholique de Louvain, Brussels, Belgium. Thomas.gerard@uclouvain.be.
  • Institute of Neurosciences, Université Catholique de Louvain, Brussels, Belgium.
  • Neurology Department, Cliniques Universitaires Saint Luc, Brussels, Belgium.
  • Nuclear Medicine Department, Cliniques Universitaires Saint Luc, Brussels, Belgium.
  • WELBIO Department, WEL Research Institute, Avenue Pasteur, 6, 1300, Wavre, Belgium.

ORCID-Profile: Thomas Gérard, Lise Colmant, Vincent Malotaux, Yasmine Salman, Lara Huyghe, Lisa Quenon, Laurence Dricot, Renaud Lhommel, Bernard Hanseeuw

Förderung

  • Fonds De La Recherche Scientifique - FNRS

Zitieren

APA

Gérard, T., Colmant, L., Malotaux, V., Salman, Y., Huyghe, L., Quenon, L., Dricot, L., Ivanoiu, A., Lhommel, R., & Hanseeuw, B. (2024). The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging, 51(6), 1662-1674. https://doi.org/10.1007/s00259-024-06603-2

Vancouver

Gérard T, Colmant L, Malotaux V, Salman Y, Huyghe L, Quenon L, et al. The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(6):1662-1674. doi:10.1007/s00259-024-06603-2

BibTeX
@article{Grard2024,
  author = {Gérard, Thomas and Colmant, Lise and Malotaux, Vincent and Salman, Yasmine and Huyghe, Lara and Quenon, Lisa and Dricot, Laurence and Ivanoiu, Adrian and Lhommel, Renaud and Hanseeuw, Bernard},
  title = {The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer’s disease},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  volume = {51},
  number = {6},
  pages = {1662--1674},
  doi = {10.1007/s00259-024-06603-2}
}
Kostenlos starten →